HomeCompareBEVVF vs JNJ

BEVVF vs JNJ: Dividend Comparison 2026

BEVVF yields 285714.29% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BEVVF wins by $1.734986541242196e+31M in total portfolio value
10 years
BEVVF
BEVVF
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full BEVVF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BEVVF vs JNJ

📍 BEVVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBEVVFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BEVVF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BEVVF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BEVVF
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, BEVVF beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BEVVF + JNJ for your $10,000?

BEVVF: 50%JNJ: 50%
100% JNJ50/50100% BEVVF
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BEVVF
No analyst data
Altman Z
-23.9
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BEVVF buys
0
JNJ buys
0
No recent congressional trades found for BEVVF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBEVVFJNJ
Forward yield285714.29%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$1.734986541242196e+31M$20.0K
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00$827.78
Total dividends collected$1.734908400352195e+31M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BEVVF vs JNJ ($10,000, DRIP)

YearBEVVF PortfolioBEVVF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$28,582,129$28,571,428.57$10,676$355.77+$28.57MBEVVF
2$76,351,353,429$76,320,770,551.21$11,407$389.39+$76351.34MBEVVF
3$190,619,493,207,524$190,537,797,259,355.30$12,198$426.53+$190619493.20MBEVVF
4$444,781,927,427,195,200$444,577,964,569,463,100.00$13,056$467.62+$444781927427.18MBEVVF
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$13,987$513.12+$969967353346567.13MBEVVF
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$14,998$563.56+$1976961629315092992.00MBEVVF
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$16,098$619.52+$3.765923944594039e+21MBEVVF
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$17,295$681.69+$6.704681437057683e+24MBEVVF
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$18,599$750.82+$1.1156275836497015e+28MBEVVF
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$20,022$827.78+$1.734986541242196e+31MBEVVF

BEVVF vs JNJ: Complete Analysis 2026

BEVVFStock

Bee Vectoring Technologies International Inc., an agriculture technology company, develops and provides natural commercial farming solutions. Its solutions include the Hive and Bees, an inoculum dispenser system; Vectorpak with Vectorite, a recipe of ingredients that allows bees to carry crop BVT-CR7 and other beneficial fungi or bacteria in their outbound flights to the crops; active ingredients, such as BVT-CR7, an organic strain of a natural occurring endophytic fungus; and pollen distribution systems. The company's patented bee vectoring technology uses commercially-reared bees to deliver targeted crop controls through the natural process of pollination. It provides natural pest and disease management solutions for various crops, such as strawberries, sunflowers, apples, tomatoes, canola crops, blueberries, and other crops. The company was founded in 2000 and is headquartered in Mississauga, Canada.

Full BEVVF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BEVVF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BEVVF vs SCHDBEVVF vs JEPIBEVVF vs OBEVVF vs KOBEVVF vs MAINBEVVF vs ABBVBEVVF vs MRKBEVVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.